Stockholm, Sweden

Stefan Lethagen

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Lethagen

Introduction

Stefan Lethagen is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of medicine, particularly in the area of immunology. His work focuses on methods to induce immune tolerance, which is crucial for patients requiring clotting factors.

Latest Patents

Stefan Lethagen holds a patent for "Methods of inducing immune tolerance to clotting factors." This patent outlines methods for inducing immune tolerance in humans by administering an effective amount of a composition or a chimeric protein that includes a clotting factor and an Fc region. This innovative approach has the potential to improve treatment outcomes for individuals with clotting disorders.

Career Highlights

Throughout his career, Lethagen has worked with prominent companies in the biotechnology sector. He has been associated with Bioverativ Therapeutics Inc. and Swedish Orphan Biovitrum AB, where he has contributed to advancing therapeutic solutions for patients with rare diseases.

Collaborations

Stefan has collaborated with esteemed colleagues, including Jennifer A. Dumont and Nisha Jain. Their combined expertise has fostered advancements in the development of innovative therapies.

Conclusion

Stefan Lethagen's work exemplifies the impact of innovation in the medical field. His patent and collaborations highlight his commitment to improving patient care through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…